cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing CD38 is a key mediator
CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions PMC The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC
Pay in 4 interest-free payments of $6.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



